Long-term safety of sorafenib in advanced renal cell carcinoma: Follow-up of patients from phase III TARGET
Thomas E. Hutson, Joaquim Bellmunt, Camillo Porta, Cezary Szczylik, Michael Staehler, Andrea Nadel, Sibyl Anderson, Ronald Bukowski, Tim Eisen, Bernard EscudierVolume:
46
Year:
2010
Language:
english
Pages:
2441
DOI:
10.1016/j.ejca.2010.06.121
File:
PDF, 260 KB
english, 2010